To explore the effects of asbestos and silica on the human immune system, an experimental model of lowdose and long-term exposure was established using a human UTLV-l-immortalized polyclonal T cell line, MT-2 (MT-20rg). MT-2 cells were continuously exposed to asbestos at a concentration (10 ug/ml) which does not induce complete cell death during short-term exposure. After acquiring resistance to CD-induced apoptosis (designated MT-2Rst), an immunological comparison was made between the MT-20rg and MT2Rst lines in terms of T cell receptor-VO (TcR-VO) expression. MT-2Rst cells showed excess expression of various TcR-VO, although TcR-VO-overpresenting cells were characterized as undergoing apoptosis due to first contact with CD. Patients with asbestos-related diseases (AJ{D), such as asbestosis and malignant mesothelioma, were compared with silicosis (SIL) patients as a disease control and with healthy donors (UD). SIL and ARD not only differed in their causative materials, silica and asbestos as mineral silicates, but also in terms of complications; autoimmune disorders in SIL and tumors in ARD. ARD patients showed a restricted overpresentation ofTcR-VO without clonal expansion, whereas SIL patients revealed significant overpresentation of TcR-VO 7.2. These experimental and clinical analyses indicate the superantigenic and dysregulation of autoimmunity-inducing effects of asbestos and silica, respectively.Asbestos (e.g. chrysotile, crocidolite and amosite) is known to cause malignant lung cancer or mesothelioma. The International Agency for Research on Cancer (IARC) categorizes both asbestos and crystalline silica as group I carcinogens (1). According to the IARC classification, asbestos affects alveolar epithelial and mesothelial cells. There have been many studies concerning asbestosinduced apoptosis in these cells. Experimentally, these cells have undergone apoptosis on a relatively high-level, short-term exposure to asbestos via the production of ROS and RNS with activation of the mitochondrial apoptotic pathway (2-4). Thus, it has been considered that during low-level and long-term exposure to asbestos in the human body, alveolar epithelial and mesothelial cells escape from